Evidence from both mammalian and nonmammalian vertebrates indicates that intracardiac nitric oxide (NO) facilitates myocardial relaxation, ventricular diastolic distensibility, and, consequently, the Frank-Starling response, i.e., the preload-induced increase of cardiac output. Since nitrite ion (NO 2 Ϫ ), the major storage pool of bioactive NO, recently emerged as a cardioprotective endogenous modulator, we explored its influence on the Frank-Starling response in eel, frog, and rat hearts, used as paradigms of fish, amphibians, and mammals, respectively. We demonstrated that, like NO, exogenous nitrite improves the Frank-Starling response in all species, as indicated by an increase of stroke volume and stroke work (eel and frog) and of left ventricular (LV) pressure and LVdP/dt max (rat), used as indexes of inotropism. Unlike in frog and rat, in eel, the positive influence of nitrite appeared to be dependent on NO synthase inhibition. In all species, the effect was sensitive to NO scavengers, independent on nitroxyl anion, and mediated by a cGMP/PKG-dependent pathway. Moreover, the nitrite treatment increased S-nitrosylation of lower-molecular-weight proteins in cytosolic and membrane fractions. These results suggest that nitrite acts as a physiological source of NO, modulating through different species-specific mechanisms, the stretch-induced intrinsic regulation of the vertebrate heart. nitric oxide; cGMP/PKG; S-nitrosylation NITRITE (NO 2 Ϫ ), RATHER THAN being simply a product of nitric oxide (NO), has emerged as a key intrinsic signaling molecule in many biological processes (6). It represents the largest physiological reservoir of NO in various cells and tissues, and it can be reduced to bioactive NO along a physiological oxygen and pH gradient (11). In vivo, different nonenzymatic and enzymatic pathways are proposed to support the reconversion of nitrite into NO, including acidic disproportionation (35), conversion via xanthine-oxidoreductase (XOR) (30), mitochondrial enzymes (8), deoxyhemoglobin, and deoxymyoglobin (deoxyMb) (11, 19, 20, 36, 48, 45) .
NITRITE (NO 2
Ϫ ), RATHER THAN being simply a product of nitric oxide (NO), has emerged as a key intrinsic signaling molecule in many biological processes (6) . It represents the largest physiological reservoir of NO in various cells and tissues, and it can be reduced to bioactive NO along a physiological oxygen and pH gradient (11) . In vivo, different nonenzymatic and enzymatic pathways are proposed to support the reconversion of nitrite into NO, including acidic disproportionation (35) , conversion via xanthine-oxidoreductase (XOR) (30) , mitochondrial enzymes (8) , deoxyhemoglobin, and deoxymyoglobin (deoxyMb) (11, 19, 20, 36, 48, 45) .
The importance of nitrite-mediated NO production has also been shown in the cardiovascular system, particularly in relation to vasodilation (31) , angiogenesis (27) , and cardioprotection (5, 13) . In a comparative perspective, we recently reported that nitrite elicited negative inotropism in eel, frog, and rat hearts, suggesting that in both mammalian (rat; Ref. 41 ) and cold-blooded (frog and eel; Ref. 9 ) vertebrate hearts, nitrite represents a significant source of bioactive NO that modulates cardiac performance. Of note, in the three vertebrate paradigms, characterized by diverse heart morphologies and blood supply patterns (see, for details, Ref. 9), the nitrite-dependent inotropic effect showed species-specific transduction mechanisms. In fact, it appeared to be dependent on nitric oxide synthase (NOS) activity in fish, sensitive to NO scavenging, and cGMP/PKG dependent in eel, frog, and rat.
The Frank-Starling mechanism (heterometric cardiac regulation) is a fundamental property of all vertebrate hearts, which allows the myocardium to respond to increased venous return (preload) with a more vigorous contraction of its lengthened fibers, thus increasing stroke volume (SV) and consequent cardiac output (CO; the product of heart rate and stroke volume). However, the relative importance of the Frank-Starling mechanism regarding CO increase varies among vertebrates. In fact, in response to hemodynamic loads, mammals increase CO mainly through heart rate (HR), amphibians through both HR and SV modulation, while fish largely enhance SV (47) . It seems that the major difference in cardiac mechanosensitivity between mammalian and amphibian/fish myocytes appears related to the sarcomere length-tension relationship (47) .
Although it has been assessed that NO decreases the diastolic stiffness, thus significantly contributing to the FrankStarling response in mammals (7) and fish (14) , nothing is known concerning the putative nitrite involvement on this fundamental heart property.
The aim of this study was to test the hypothesis that nitrite may be involved in the heterometric regulation either through reduction to NO and consequent cGMP signaling, and/or through S-nitrosylation of cardiac proteins. Therefore, we analyzed the influences of nitrite on the response to preload increase of the isolated and perfused working hearts of fish (Anguilla anguilla) and frog (Rana esculenta), as well as of the isovolumic Langendorff perfused rat heart. The results obtained validated our hypothesis. At the same time, the comparative approach using different cardiac designs provided insights on "ancestral" functions of the cardiac nitrite-NO system in vertebrates, hopefully expanding its actual physiopathological significance in enhancing cardiac mechanical efficiency and contractility in humans.
MATERIALS AND METHODS

Animals
European eels (A. anguilla L.) and frogs (R. esculenta) of both sexes, weighing 80 -110 g and 15-25 g, respectively, were provided by a local hatchery and kept at room temperature (18 -20°C) without feeding for 5-7 days. In accordance with the accepted standards of animal care, the experiments were organized to minimize stress and the number of animals used. Animal care and experiments were in accordance with the Italian law (DL 116, January 27, 1992).
Male Wistar rats (Harlan Laboratories, Udine, Italy) weighing 180 -240 g were housed in a ventilated cage rack system under standard conditions. Animals had free access to food and water. Animal care, death, and experiments were supervised according to the Guide for the Care and Use of Laboratory Animals [U.S. National Institutes of Health (NIH), publication no. 85-23, revised 1996].
Isolated and Perfused Working Heart Preparations
Eels were anesthetized in benzocaine (0.2 g/l) for 15 min. The animals were opened ventrally behind the pectoral fins. The hearts, removed without the pericardium and cannulated, were transferred to a perfusion chamber filled with Ringer solution and connected with a perfusion apparatus (21) . The composition of the perfusate (mmol/l) was 115.17 NaCl, 2.03 KCl, 0.37 KH 2PO4, 2.92 MgSO4, 50 (NH4)2SO4, 1.27 CaCl2, 5.55 glucose, and 1.90 Na2HPO4; pH was adjusted to 7.7-7.9 by adding NaHCO3 (about 1 g/l); Ringer solution was equilibrated with a mixture of O2:CO2 at 99.5:0.5%.
Frogs were pithed and ventrally opened; the pericardium was removed, and the heart was cannulated in situ with polyethylene cannula inserted into the sinus venosus for the inflow and into the left aortic trunk for outflow collection, and connected to a perfusion apparatus (15) . Right aortic trunk, right and left praecava veins, and pulmonary vein were tied off by ligature. Frog Ringer solution contained (mmol/l): 115 NaCl, 2.5 KCl, 1.0 CaCl 2, 2.15 Na2HPO4, 0.85 NaH2PO4, and 5.6 glucose; pH was adjusted to 7.3 by adding Na2HPO4. The saline was equilibrated with air.
The experiments were performed at room temperature (18 -20°C). Pressures were measured by two MP-20D pressure transducers (Micron Instruments, Simi Valley, CA) in conjunction with a PowerLab data acquisition system and analyzed using Chart software (ADInstrument, Basile, Italy). Pressure measurements (input and output) were expressed in kilopascals and corrected for resistances of cannula and length of tubes. CO was collected over 1 min and weighed. HR was calculated from pressure recording curves. SV (ml/kg; CO/HR) was used as a measure of ventricular performance (i.e., index of inotropism). Ventricular stroke work [SW; mJ/g; (afterload-preload) ϫ SV/ventricle mass] served as an index of systolic functionality. To analyze the inotropic effects without the confounding chronotropic action of substances, the preparations were electrically paced.
In all experiments, the control conditions were A. anguilla, mean output pressure 3.00 kPa with cardiac output set to 10 -12 ml·min Ϫ1 ·kg Ϫ1 body mass (21) ; and R. esculenta, mean output pressure 3.92 kPa with cardiac output set to 110 ml·min Ϫ1 ·kg Ϫ1 body mass (15) . Hearts that did not stabilize within 10 -15 min from the onset of perfusion were discarded.
Langendorff Perfused Rat Heart
Rats were anesthetized by intraperitoneal injection of ethyl carbamate (2 g/kg body wt). To measure left ventricular pressure, a water-filled latex balloon connected to a blood pressure transducer gauge (WRI, World Precision Instruments, Sarasota, FL) was inserted through the mitral valve into the left ventricle to allow isovolumic contractions and to continuously record mechanical parameters. The balloon was progressively filled with water to obtain an initial left ventricular end diastolic pressure of 5 to 8 mmHg (3). The perfusion solution consisted of a modified nonrecirculating Krebs-Henseleit solution containing (mmol/l) 113 NaCl, 4.7 KCl, 25 NaHCO 3, 1.2 MgSO4, 1.8 CaCl2, 1.2 KH2PO4, 11 glucose, 1.1 mannitol, 5 Napyruvate 5 (pH 7.4; 37°C; 95% O2-5% CO2).
Hemodynamic parameters were assessed using a PowerLab data acquisition system and analyzed using Chart software (ADInstruments). Heart performance was evaluated from LV pressure (LVP, in mmHg), an index of contractile activity; rate-pressure product [RPP: HR ϫ LVP, in 10 4 mmHg ϫ beats/min (bpm)], an index of cardiac work; maximal value of the first derivative of LVP (mmHg/s), an index of the maximal rate of LV contraction; and time to peak tension of isometric twitch, an assessment of inotropism. Lusitropism was determined by the maximal rate of LVP decline, (LVdP/dt) min (mmHg/s), the half time relaxation (s), which is the time required for tension to fall from the peak to 50%, and T/-t ratio (the ratio between the maximal rate of LV contraction and maximal rate of LV relaxation) obtained by ϩ(LVdP/dt)max/Ϫ(LVdP/ dt)max. Mean coronary pressure was calculated by averaging values obtained during several cardiac cycles (3).
Experimental Protocol: Frank-Starling Response
Eel and frog. To assess the interaction between nitrite and the Frank-Starling response, a Starling curve was generated by increasing filling pressure in a stepwise manner, from 0.15 to 0.35 kPa (frog) and from 0.2 to 0.6 kPa (eel). After baseline assessment, the input pressure was brought to the control condition, and a second Starling curve was generated in the presence of nitrite (eel: 10 Ϫ6 M; frog: 10 Ϫ5 M). In a second series of experiments, after 10 min of perfusion with vehicle enriched with either the endothelial NOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME), or the NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazolineoxyl-1-oxyl-3-oxide (PTIO), or the nitroxyl anion (HNO) scavenger N-acetyl-L-cysteine (NAC), or the soluble guanylyl cyclase (sGC) specific inhibitor 1-H-[1,2,4]oxadiazole-[4,3-a]quinoxalin-1-one (ODQ), or the PKG antagonist, KT 5823, or the SERCA2a pump inhibitor, thapsigargin, a first Frank-Starling curve was generated, then, the input pressure was brought to the control condition, and a second curve was generated in the presence of nitrite plus the specific inhibitor. The time factor (i.e., the "memory" of the heart) of loading stimulation was excluded, as with our previous studies (14, 21) .
Rat. By carrying out similar protocols, Starling curves were generated by increasing the volume of the intraventricular balloon in six steps each using 10 l. Cardiac function was assessed within 1 min from each volume increment, corresponding to the setting of a new steady state. The complete assessment of the Frank-Starling response was accomplished within 15 min.
ELISA Measurements of Intracellular cGMP/cAMP
Acid extracts of frozen heart tissue (endocardial tissue and cardiomyocytes from atria and ventricles) used for cGMP and cAMP determinations (200 -300 mg) were treated with 6% trichloroacetic acid at 0°C and centrifuged at 10,000 g for 10 min. The supernatant was extracted 3 times with 3 ml of diethyl ether saturated with water, and the aqueous phase was collected and stored at Ϫ80°C. cGMP and cAMP concentrations were measured using a commercial enzyme immunoassay (Biotrak enzyme immunoassay system; Amersham Biosciences, Piscataway, NJ).
Biotin Switch Assay and Western Blot Analysis
The biotin switch assay was used to evaluate protein S-nitrosylation. Ventricle homogenates were centrifuged at 4°C for 1 h at 25,000 g in 20 mM Tris pH 7.5, 150 mM NaCl, 1% Igepal CA 630, 0.5% sodium deoxycholate, 1 mM EDTA, 0.1% SDS, 200 mM sodium orthovanadate and protease inhibitor cocktail, using a polytron tissue grinder. Proteins contained in both the supernatant (cytosolic fraction) and pellet (membrane fraction resuspended in homogenization buffer) were quantified with Bradford reagent. The biotin switch assay was performed as previously described (9) . To detect biotinylated proteins, samples from the biotin switch assay were separated on 15% and on 10% SDS-PAGE gels, transferred to membrane, blocked with nonfat dried milk, and incubated with streptavidin-peroxidase diluted 1:5,000 for 1 h. Immunodetection for both Western blot analysis and biotin switch assay was performed using an enhanced chemiluminescence kit (ECL PLUS; Amersham). Autoradiographs were obtained by exposure to X-ray films (Hyperfilm ECL; Amersham). Immunoblots were digitalized, and the densitometric analysis of the bands was carried out using NIH IMAGE 1.6 for a Macintosh computer based on 256 gray values (0 ϭ white; 256 ϭ black).
To evaluate differences in protein phosphorylation, cardiac ventricular homogenates were used. Cardiac ventricles, obtained after perfusion with vehicle alone and after nitrite Starling treatment, were homogenized in ice-cold RIPA buffer (Sigma Aldrich, Milan, Italy) containing a mixture of protease inhibitors (1 mmol/l aprotinin, 20 mmol/l phenylmethylsulfonyl fluoride and 200 mmol/l sodium orthovanadate). The homogenates were centrifuged at 200 g for 10 min at 4°C to remove debris. Protein concentration was determined using Bradford reagent, according to the manufacturer's recommendations (Sigma-Aldrich). Proteins were separated on 8% SDS-PAGE gels, transferred to membrane, blocked with nonfat-dried milk, and incubated overnight at 4°C with polyclonal rabbit anti-antibody [polyclonal rabbit anti-eNOS antibody (Sigma) or polyclonal rabbit anti phospho-eNOS antibody Ser 1177 (Santa Cruz Biotechnology, Santa Cruz, CA)] diluted 1:1,000 in TBS-T containing 5% nonfat dried milk. Anti-rabbit secondary antibody peroxidase linked (Santa Cruz Biotechnology) was diluted 1:2,000 in TBS-T containing 5% nonfat dried milk.
Drugs and Chemicals
All of the solutions were prepared in double-distilled water. ODQ was prepared in ethanol. Dilutions were made in Ringer solution immediately before use. L-NAME, ODQ, PTIO, and NAC were purchased from Sigma Chemical (St. Louis, MO). KT 5823 and thapsigargin were purchased from Calbiochem (Milan, Italy).
Statistics
The results are expressed as means Ϯ SE of absolute values. Multiple comparisons were assessed by using two-way ANOVA followed by Bonferroni's post hoc test. Statistical significance was established at P Ͻ 0.05. The results of absorbance measurements and the gray values obtained from the densitometric analysis were expressed as means Ϯ SE of determinations for each sample. To test the difference between the groups, one-way ANOVA was performed. Statistical significance was established at P Ͻ 0.001.
RESULTS
Baseline hemodynamic parameters after stabilization are reported in Table 1 (eel and frog) and in Table 2 (rat).
Nitrite Influence on the Heterometric Regulation
Previous studies performed on eel, frog (9) , and rat (41) hearts have demonstrated that nitrite induced dose-dependent negative inotropic effect from 10 Ϫ9 to 10 Ϫ4 M. To determine nitrite effects on the Frank-Starling response, the cardiac response to preload increases was evaluated before and after nitrite treatment. Nitrite concentrations were chosen as the first concentrations, which significantly modulated basal cardiac performance (eel: 10 Ϫ6 M; frog: 10 Ϫ5 M; rat: 10 Ϫ8 M). In all preparations, a significant nitrite-induced increase (SV in eel and frog; LVP and LVdP/dt max in rat) of the Frank-Starling response ( Fig. 1 ) was observed. In addition, in the rat, a significant change of myocardial relaxation, documented by LVdP/dt min, was reported (Fig. 1) . Preliminary experiments showed that in all species, under basal conditions, the effects of nitrite reached a maximum at 5 min after initial exposure and remained stable up to 15-20 min. The assessment of each Frank-Starling curve was completed within this time.
Control experiments with the L-type calcium channel antagonist diltiazem, a NO-independent negative inotrope, failed to modify the Starling response (eel: Ref. 14; rat: unpublished data).
Role of NOS-NO and HNO
To clarify whether the nitrite-dependent Starling response involves NOS-produced NO, we exposed the isolated hearts of all species to nitrite plus the NOS inhibitor L-NAME (10 Ϫ5 M). Although in the eel, this treatment abolished the positive nitrite-dependent increase of the Starling response, in frog and rat, it was not modified (Fig. 2) . This was confirmed by the increase of p-eNOS expression in the eel (see Fig. 2, inset) . The involvement of endogenously generated NO was also evaluated using the NO scavenger PTIO (10 Ϫ7 M), which abolished the nitrite-induced response in all species (Fig. 3) . Because nitrite may also be reduced to nitroxyl (HNO), a powerful oxidant and S-nitrosylating (39) and positive inotropic agent (40), we performed Starling curves in the presence of the HNO scavenger NAC. Results indicated that the effects of nitrite on the preload-induced increases of SV were independent from HNO generation in all species (Fig. 3) .
Involvement of cGMP-PKG Pathway and SERCA2a Pump
Several studies have shown that NO exerts an important modulation of cardiac performance via sGC signaling (2, 34) . To determine whether this mechanism is involved in the nitrite-dependent modulation of the Starling response, the hearts were treated with nitrite in the presence of ODQ (10 Ϫ5 M), a potent oxidant and soluble guanylate cyclase inhibitor. Because ODQ blocked the nitrite-dependent response in all species (Fig. 4) , to further test the involvement of the cGMP pathway, we inhibited PKG, a downstream target of sGC and cGMP, with KT 5823 (10 Ϫ7 M). This abolished the nitritedependent response in all species (Fig. 4) , thus supporting the involvement of the NO-sGC-PKG signaling in the nitriteinduced heterometric modulation.
Consistent with nitrite signaling through cGMP, we found that in all species, intracardiac cGMP levels resulted in higher nitrite-dependent Starling responses with respect to both the Starling-treated and control hearts (see Fig. 4, inset) . On the other hand, cAMP levels had no significant differences (see Table 3 ).
NO has been implicated in the modulation of Ca 2ϩ cycling in the stretched myocardiocytes, influencing Ca 2ϩ channels and SERCA2a pumps (33, 42, 50) . Therefore, to evaluate the possible intracellular calcium involvement in response to preload increases, we treated the heart preparations with nitrite plus thapsigargin, an inhibitor of SERCA2a pumps. In all species, thapsigargin significantly reduced the positive nitrite- dependent Starling response (Fig. 5) , suggesting a nitritederived NO involvement in the rate of sarcoplasmic reticulum (SR) Ca 2ϩ reuptake.
S-Nitrosylated Proteins
To have preliminary information on whether the nitriteinduced heterometric regulation is accompanied by cardiac protein S-nitrosylation, we analyzed, using the biotin switch method, the pattern of proteins containing S-nitrosylated cysteines in homogenates of control and nitrite-treated hearts. The nitrite treatment induced an increase of S-nitrosylation of lower-molecular-weight proteins in cytosolic (frog and rat) and membrane (eel) fractions (Fig. 6 ). This increment, as indicated by densitometric analysis, was significant in eel and frog hearts (Fig. 6 ).
DISCUSSION
Recent evidence indicates that nitrite exerts important actions on the cardiovascular system under normal and physiopathological conditions (58) . These actions mimic the NOinduced cardiovascular effects and include hypoxic vasodilation (11, 12) and cardioprotection following ischemia/ reperfusion (13, 17, 25, 52) . They are thought to be dependent on the nitrite reduction to NO, as well as to NO-independent processes, e.g., through direct S-nitrosylation of thiol-containing proteins (6) . However, the direct NO 2 Ϫ -elicited effects on myocardial inotropism and lusitropism have received, up to now, less attention, thus requiring deeper analysis. Using the same eel, frog, and rat heart preparations of the present study, we previously showed that under basal (nonstimulated) conditions, nitrite exerts negative inotropic influence, regardless of the different intracardiac blood supply organization, i.e., either avascular (frog) or poorly (eel) or richly (rat) vascularized types of ventricular myoangioarchitecture. Although rodents, for their particularly accelerated excitation-contraction coupling, do not represent the ideal model to study Starling response in mammals (in literature, other models, such as guinea pigs or dogs, are used; Refs. 26, 44, 51), several studies (see, for example, Refs. 38, 43, 49) analyzed the Frank-Starling response on the rat heart. In the present study, we decided to utilize the same models of fish, amphibians and mammals previously used to demonstrate the effect of nitrite under basal conditions (9, 41) , proposing the rat as a mammalian paradigm.
The fact that in eel, frog (9) , and rat (41) The most prominent result of the present study is the demonstration, for the first time, that nitrite profoundly influences a fundamental property of the vertebrate myocardium, that is, its ability to increase contractility in response to an increased muscle length (stretch), i.e., the heterometric regulation (Frank-Starling mechanism). The improved nitrite-dependent Frank-Starling response is attained through an intracardiac NO 2 Ϫ -mediated NO production, which involves activation of sCG/cGMP/PKG pathway.
Moreover, our results suggest that in conjunction with the classical cGMP/PKG cascade, the Starling response may be modulated by nitrite also through S-nitrosylation of specific targets, which need to be yet identified.
Nitrite-Generated NO and the Starling Response
Nitrite significantly enhanced the preload-induced increases of SV and SW in the eel and frog working heart preparations, as well as LVP and LVdP/dt max in the isovolumic Langendorff rat preparation. Noteworthy, in the latter, which allows an accurate analysis of lusitropism, the minimal negative derivative of intraventricular pressure, and LVdP/dt min, was positively affected by nitrite, suggesting the anion involvement not only in the systolic but also in the diastolic phase. At the max preload value, the percentage increments of nitrite-treated hearts vs. controls were about 49% (SV) in eel, 40% (SV) in frog, and 51% (LVP) in rat. When these values are compared with the percentage decreases of inotropism detected under basal conditions at the same respective concentrations (eel: 10 Ϫ6 M; frog: 10 Ϫ5 M; rat: 10 Ϫ8 M), it is evident that the nitrite-induced effects reach higher levels in the Starlingtreated hearts (eel: Ϫ11%; frog: Ϫ8%; rat: Ϫ28%). This might Noteworthy, although exerting a well-known negative inotropism, NO significantly improves the Frank-Starling response (mammals: 44; fish: 14). This occurs through different mechanisms. In fact, the NO-dependent activation of the cGMP-PKG pathway, through the troponin I phosphorylation and the subsequent reduced affinity of troponin C for calcium, negatively regulates cardiac contractility; on the other hand, the NO-dependent SERCA2a pump modulation provides a way to rapidly adapt myocardial contractility in response to preload changes (33) . In particular, the NO-dependent myocardial relaxation is associated with SERCA2a-induced increase in calcium reuptake into the SR (33, 57) . Therefore, the NO signal can activate in a spatio-temporal-dependent manner different intracellular targets mediating distinct responses within the same cell type.
The significant differences between the Starling curves obtained, with and without the anion, highlight the nitrite implication in the heterometric regulation, strongly supporting the idea that NO 2 Ϫ acts as an endogenous source of NO not only under basal, but also under increased myocardial stretch, conditions. This was supported by the finding that the nitritedependent improvement of Starling response was inhibited by the NO scavenger PTIO. Nitrite may be reduced endogenously to HNO, a potent oxidant and S-nitrosylating agent, which can be putatively generated from NOS-dependent and -independent sources (55). HNO induces myocardial inotropic effect opposite to NO, since, in contrast to the generally negative inotropism of its redox sibling, it increases contractility (23). Our results show that the nitrite-dependent modulation of the Starling response is insensitive to NAC, a specific HNO scavenger, suggesting that the nitroxyl reduction of nitrite is not substantially involved in this response. However, because of the antioxidant property of NAC (23, 55) , the specificity of this response remains to be further corroborated.
Taken together, these data strongly support the idea that the NO 2 Ϫ -enhanced Starling response is caused directly by an intracardiac nitrite-mediated NO production. 
NOS-Dependent and -Independent Mechanisms
In the heart, nitrite reduction to NO can occur through both nonenzymatic and enzymatic mechanisms controlled by pH, oxygen tension, nitrite levels, and reducing substrates. The enzymatic mechanisms include NOS-dependent and -independent pathways (45, 58) . Interestingly, we have observed that NOS inhibition by L-NAME abolished the positive nitrite-dependent increase of Starling response in eel, but it was ineffective in frog and rat. Similarly, we previously found that in the same three heart preparations tested under basal (nonstimulated) conditions, tonic nitriteinduced negative inotropism is NOS-dependent in eel (9), but NOS-independent in frog (9) and rat (41) . It is, therefore, conceivable that in the eel heart, the NOS enzyme acts as a nitrite-reductase, according to evidence in both mammals (48) and fish, indicating that a functional NOS appears essential for the nitrite-induced inotropism (9) . In contrast, in the frog and rat hearts, numerous metal-containing and ferrous heme proteins (xanthine oxido-reductase, cytoglobin, deoxyMb, mitochondrial electron transport enzymes, cytochrome P-450) other than NOS can be involved in the NO 2 Ϫ -induced NO production under aerobic conditions; however, their participation remains to be clarified.
cGMP-Transduction Signaling
It was previously demonstrated that in eel, frog, and rat hearts, a functioning NO axis modulates mechanical perfor- mance via a NO-dependent increase in cGMP levels both under basal and chemically stimulated conditions (22, 46) .
Several studies suggest that both cGMP-dependent and -independent mechanisms contribute to the NO-mediated influence on Frank-Starling response. NO activates sGC by binding to its heme moiety, leading to cGMP production, whereby, among other effects, it induces myofilament desensitization to Ca 2ϩ , and thus accelerated myocardial relaxation (28, 44) . Moreover NO, through cGMP-independent mechanisms, could modulate the preload-induced increase of the contractile force through direct reaction with thiol residues of several compounds or proteins (18) . These cGMP-dependent and -independent mechanisms have been related to different NOS isoform compartmentation, as well as to differences in their mode of stimulation. It is now generally accepted that in addition to eNOS localized in coronary and EE cells (paracrine action), both eNOS and neuronal (nNOS) are constitutively expressed in distinct subcellular locations within cardiomyocytes (autocrine action) (46) . Evidence suggests that myocardial eNOS, mostly expressed into caveolae, primarily mediates the inotropic response to sustained stretch through a mechanism that involves S-nitrosylation of thiol residues in the ryanodine receptors' Ca 2ϩ release channels (33) , while the myocardial nNOS, first observed in the sarcoplasmic reticulum (SR) (56) and also found later at the level of sarcolemmal membrane proteins (54), mainly promotes left ventricular relaxation by regulating the PKA-mediated phosphorylation of phospholamban (PLN) and the rate of SR Ca 2ϩ reuptake by SR Ca 2ϩ ATPase (SERCA2a) (57) . We have recently reported that in the eel, an eNOS-derived endogenous NO influences the Frank-Starling response, inducing a beat-tobeat regulation of calcium reuptake and thus of myocardial relaxation (14) . This occurs through a transduction mechanism which, independently from cGMP/PKG pathway, involves a modulation of SR Ca 2ϩ reuptake through PLN S-nitrosylation (14) .
Notably, the present data indicate that in all species, irrespective of the NOS-dependent (eel) or -independent (frog and rat) source of bioactive NO, the nitrite-induced effects on Frank-Starling response involve a cGMP-PKGmediated mechanism. In fact, it is strikingly affected by pretreatment with either the sGC inhibitor ODQ or the PKG antagonist KT 5823 . Since ODQ is a potent inhibitor of sGC but also an oxidant to heme proteins (1, 16) , it is possible that, in addition to the major inhibition of the NO-sGMP pathway, the ODQ-dependent response may partly result also from inhibition of nitrite conversion to NO through cardiac heme proteins under aerobic conditions. According to the emerging scenario, in the Starling-treated hearts, nitrite acts as a paracrine stimulus of NO production, which, in turn, diffuses in the myocardial cell, thereby activating the sGC and its downstream PKG signaling cascade.
S-Nitrosylated Proteins
The protein S-nitrosylation, i.e., the covalent adduction of a nitroso group to a cysteine thiol side chain, has recently emerged as a major mechanism by which NO mediates a large number of intracellular processes (18) . Using the biotin switch method (24), we evaluated the level of S-nitrosylated proteins in the hearts of eels, frogs, and rats treated with nitrite. Our results showed that nitrite, together with the activation of cGMP-PKG pathway, induced an increase of protein S-nitrosylation, particularly evident in eel and frog hearts. This suggests that this mechanism could be more important in nonmammalian than in mammalian hearts. Whether S-nitrosylation represents a potential additive mechanism by which nitrite determines the cardiac effects revealed by the present study needs further investigation.
Potential targets of S-nitrosylation include G protein-coupled receptor signaling (37, 53) , Hsp90, a chaperone involved in eNOS activation (32) , death receptor-mediated signaling (4), and mitochondrial proapoptotic and antiapoptotic cascades (10) . In this view, mitochondria deserve particular attention, also in light of the inhibition exerted by nitrite-derived NO on mitochondrial respiration observed by Shiva et al. (48) in both heart homogenate and isolated cardiomyocytes. In addition, S-nitrosylation modulates calcium and potassium channels and calcium cycling, regulating SERCA2a by phospholamban. Indeed, very recently, Garofalo et al. (14) demonstrated that NO modulates the Starling response through a phospholamban S-nitrosylation. Presently, our laboratory is carrying out a study to identify the final molecular targets of S-nitrosylation processes in the heart.
Perspectives and Significance
The demonstration that in more than one group (mammals) of vertebrates, nitrite is a positive heterometric myocardial modulator, provides further evidence on its ubiquitous cardiac function. Specifically, the nitrite-improved myocardial contractility may represent a relevant part of the cardioprotective scenario proposed for this molecule and based on the interdependency of several factors. This may be of particular concern regarding disease states characterized by ventricular dilation (e.g., heart failure) or diminished autonomic heart modulation accompanied by increased afterload (as in old human subjects).
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